content

Small Molecule Innovator CDMO Market Poised For Huge Growth

The projected worth of the Global Small Molecule Innovator CDMO Market is anticipated to surpass $76.50 billion by 2031, displaying a compounded annual growth...

Parexel, Partex Partner to Accelerate Drug Discovery and Development

Parexel, a CRO providing a full range of Phase I to IV clinical development services, and Partex, a digital pharma platform, entered a strategic...

AGC Biologics, Asahi Kasei Enter Clinical Drug Substance Agreement

AGC Biologics, a global biopharmaceutical CDMO, entered a new agreement with Asahi Kasei Pharma to produce clinical drug substance for antibody-based therapies at AGC...

Chiesi, Aliada Therapeutics Enter Drug Delivery Alliance

Chiesi Global Rare Diseases has entered a co-development agreement with Aliada Therapeutics, a biotechnology company developing a novel blood-brain barrier (BBB)-crossing platform technology to...

Croda Pharma introduces new bioprocessing solutions to replace banned materials

Croda Pharma has introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™,...

Refeyn Expands into AAV – based Gene Therapy Manufacturing with GMP Software

Refeyn®, the leading global manufacturer of mass photometry instruments and technology, has unveiled its latest innovation, a software package designed to expand the use...

RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, is proud to announce its RBQMLive event...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read